• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue7

The Utility Of Galectin-3 And Hector Battifora Mesothelial Epitope (HBME)-1 In Differentiating Thyroid Lesions

    Upik Anderiani Miskad Winny Natacia Leiwakabessy Meilany Feronika Durry Halidah Rahawarin Muhammad Husni Cangara Truly Djimahit

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 1177-1182

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The aim of this study is to determine the utility of galectin-3 and HBME-1 in the differentiation between benign and malignant thyroid lesions. We evaluated the immunohistochemical expression of 64 thyroid lesions including non-neoplastic lesions and neoplastic lesions. Galectin-3 immunostaining was positive in 100% of papillary carcinomas, 62.5% of follicular carcinomas, 18.8% of follicular adenomas and negative in all nodular goiter as non -neoplastic lesions. HBME-1 immunostaining was positive in 93.8% of papillary carcinomas, 81.3% of follicular carcinomas, 25% of follicular adenomas and negative in all nodular goiter. There was a significant difference between benign and malignant thyroid lesion for galectin-3 and HBME-1 (p<0.001). The sensitivity, specificity, positive predictive values and negative predictive values for HBME-1 and galectin-3 is over 80%. When both markers are combined, the values of each predictive parameter were 93.75%, 81.25%, 83.33% and 92.85%. The diagnostic accuracy for both markers was 87.50%. Combining both markers will be more helpful to differentiate malignant and benign thyroid lesions.
Keywords:
  • PDF (678 K)
  • XML
(2020). The Utility Of Galectin-3 And Hector Battifora Mesothelial Epitope (HBME)-1 In Differentiating Thyroid Lesions. European Journal of Molecular & Clinical Medicine, 7(7), 1177-1182.
Upik Anderiani Miskad; Winny Natacia Leiwakabessy; Meilany Feronika Durry; Halidah Rahawarin; Muhammad Husni Cangara; Truly Djimahit. "The Utility Of Galectin-3 And Hector Battifora Mesothelial Epitope (HBME)-1 In Differentiating Thyroid Lesions". European Journal of Molecular & Clinical Medicine, 7, 7, 2020, 1177-1182.
(2020). 'The Utility Of Galectin-3 And Hector Battifora Mesothelial Epitope (HBME)-1 In Differentiating Thyroid Lesions', European Journal of Molecular & Clinical Medicine, 7(7), pp. 1177-1182.
The Utility Of Galectin-3 And Hector Battifora Mesothelial Epitope (HBME)-1 In Differentiating Thyroid Lesions. European Journal of Molecular & Clinical Medicine, 2020; 7(7): 1177-1182.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 178
  • PDF Download: 235
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus